News|Articles|October 31, 2024
WCG Meets Enrollment 24 Months Early for Top 5 Pharma’s Decentralized Trial
Author(s)WCG Clinical
A sponsor needed to get their Phase II dermatology study enrollment back on track. The study was underway for 11 months across 32 sites globally with only 20 subjects enrolled to date. With WCG support, enrollment was concluded 24 months ahead of schedule.
Trending on Applied Clinical Trials Online
1
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
2
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
3
ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion
4
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
5